rufloxacin has been researched along with E coli Infections in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, D; Cesana, M; Hübner, A; Plétan, Y; van Breukelen, G; van den Berg-Segers, A | 1 |
| Aguilar, L; Balcabao, IP; Costa, J; Dal-ré, R; Martín, M; Prieto, J; Salvá, P | 1 |
| Aguilar, L; Caffaratti, J; Dal-Ré, R; Dalet, F; Del Río, G | 1 |
| Braga, PC; Dal Sasso, M; Sala, MT | 1 |
| Caglio, G; Cantoni, L; Carmignani, G; Gusmitta, A; Maffezzini, M; Monti Bragadin, C; Samer, L | 1 |
3 trial(s) available for rufloxacin and E coli Infections
| Article | Year |
|---|---|
Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Escherichia coli Infections; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Pyelonephritis; Quinolones; Treatment Outcome | 1995 |
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.
Topics: Adult; Anti-Infective Agents; Bacteriuria; Cross-Over Studies; Escherichia coli Infections; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Serum Bactericidal Test; Staphylococcal Infections | 1996 |
Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations.
Topics: Adult; Anti-Infective Agents; Cystitis; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Quinolones; Recurrence | 1996 |
2 other study(ies) available for rufloxacin and E coli Infections
| Article | Year |
|---|---|
Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors.
Topics: Anti-Infective Agents; Bacterial Adhesion; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Neutrophils; Phagocytosis; Quinolones; Respiratory Burst; Virulence | 1999 |
[Treatment with rufloxacin of complicated urinary tract infections].
Topics: Adult; Aged; Anti-Infective Agents; Cystitis; Drug Evaluation; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones | 1992 |